Brockhaus Capital Management AG / Key word(s): Patent/Market launch
BCM subsidiary Palas announces patent filing for a measuring device for the immediate determintation of size and number of particles in exhaled air
Frankfurt/Main, August 27, 2020.
Brockhaus Capital Management AG (BKHT, ISIN: DE000A2GSU42, "BCM") announces that its subsidiary Palas GmbH Partikel- und Lasermeßtechnik ("Palas") informed BCM today that Palas filed a patent with the European Patent Office today for a measuring device for the immediate determination of size and number of particles concentration in exhaled air.
The universally applicable measuring device developed by Palas can immediately identify particles with high-resolution regarding size in the exhaled air and could thus help to detect virus infections in humans, such as COVID-19. The size and number of the particles serve as an indicator for a potential disease of the tested person.
This could especially contribute to the containment during the current COVID-19 pandemic. Due to the immense social and economic importance of the COVID-19 pandemic, BCM expects a great demand for the new measuring device. If this assumption materializes, it would have a corresponding positive effect on the sales and earnings performance of BCM.
The product launch is planned for September 2020. The patent is pending; a patent application is generally published 18 months from the filing date and only after this period, the holder is entitled to rights from the patent application.
Brockhaus Capital Management - Paul Göhring
USC - Iris C. Sistemich
|Company:||Brockhaus Capital Management AG|
|60313 Frankfurt am Main|
|Phone:||+49 (0)69 2043 409 0|
|Fax:||+49 (0)69 2043 409 71|
|Listed:||Regulated Market in Frankfurt (Prime Standard)|
|EQS News ID:||1124457|
|End of Announcement||DGAP News Service|